These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 1526527)

  • 1. Relationship of serum levels of pro-type I collagen peptide, pro-type III collagen peptide and type IV 7S collagen with cervical maturation.
    Kanayama N; Terao T
    Gynecol Obstet Invest; 1992; 34(1):24-6. PubMed ID: 1526527
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative studies of circulating KL-6, type III procollagen N-terminal peptide and type IV collagen 7S in patients with interstitial pneumonitis and alveolar pneumonia.
    Kohno N; Yokoyama A; Hirasawa Y; Kondo K; Fujino S; Abe M; Hiwada K
    Respir Med; 1997 Oct; 91(9):558-61. PubMed ID: 9415357
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased serum concentrations of procollagen peptides in essential hypertension. Relation to cardiac alterations.
    Díez J; Laviades C; Mayor G; Gil MJ; Monreal I
    Circulation; 1995 Mar; 91(5):1450-6. PubMed ID: 7867186
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic value of serum procollagen III peptide and type IV collagen in patients with biliary atresia.
    Kobayashi H; Miyano T; Horikoshi K; Tokita A
    J Pediatr Surg; 1998 Jan; 33(1):112-4. PubMed ID: 9473113
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes of serum 7S fragment of type IV collagen and N-terminal propeptide of type III procollagen after transcatheter arterial embolization as a model of acute liver injury.
    Suou T; Yamada S; Kobayashi J; Hoshino U; Nishimuki E; Kawasaki H
    Hepatology; 1993 Oct; 18(4):809-15. PubMed ID: 7691706
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum type III procollagen peptide, type IV collagen 7S domain, central triple-helix of type IV collagen and tissue inhibitor of metalloproteinases in patients with chronic viral liver disease: relationship to liver histology.
    Murawaki Y; Ikuta Y; Koda M; Kawasaki H
    Hepatology; 1994 Oct; 20(4 Pt 1):780-7. PubMed ID: 7927217
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Type III procollagen N-terminal aminopeptide and type IV collagen 7S in pleural effusion fluid].
    Tsuchiya Y; Nishikawa M; Iwamoto K; Kirioka T; Noguchi M; Watanabe A; Nishiwaki K; Nozaki Y; Nakane Y
    Nihon Kyobu Shikkan Gakkai Zasshi; 1997 Jun; 35(6):622-6. PubMed ID: 9294295
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Type III procollagen N-terminal peptide and type IV collagen-7S level in the serum and BALF of patients with non-Hodgkin's lymphoma before and after chemotherapy].
    Niitsu N; Umeda M
    Rinsho Ketsueki; 1994 Nov; 35(11):1267-75. PubMed ID: 7529840
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation between stellate cell activation and serum fibrosis markers in choline-deficient L-amino acid-defined diet-induced rat liver fibrosis.
    Hironaka K; Sakaida I; Uchida K; Okita K
    Dig Dis Sci; 2000 Oct; 45(10):1935-43. PubMed ID: 11117563
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical significance of serum 7S collagen in various liver diseases.
    Yamada S; Suou T; Kawasaki H; Yoshikawa N
    Clin Biochem; 1992 Dec; 25(6):467-70. PubMed ID: 1335851
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The significance of measurement of serum type IV 7S collagen on administration of DHA-S].
    Kanayama N; Terao T
    Nihon Sanka Fujinka Gakkai Zasshi; 1992 Feb; 44(2):239-40. PubMed ID: 1312112
    [No Abstract]   [Full Text] [Related]  

  • 12. Hepatic fibrosis in rats produced by carbon tetrachloride and dimethylnitrosamine: observations suggesting immunoassays of serum for the 7S fragment of type IV collagen are a more sensitive index of liver damage than immunoassays for the NH2-terminal propeptide of type III procollagen.
    Ala-Kokko L; Günzler V; Hoek JB; Rubin E; Prockop DJ
    Hepatology; 1992 Jul; 16(1):167-72. PubMed ID: 1618469
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Maternal serum type III procollagen peptide (P-III-P) and 7S domain of type IV collagen (7S) as indicators of placental damage caused by toxemia of pregnancy].
    Ogawa H
    Nihon Sanka Fujinka Gakkai Zasshi; 1994 Oct; 46(10):1020-6. PubMed ID: 7814931
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum concentrations of the N-terminal propeptide of type III procollagen and two type IV collagen fragments and gene expression of the respective collagen types in liver in rats with dimethylnitrosamine-induced hepatic fibrosis.
    Savolainen ER; Brocks D; Ala-Kokko L; Kivirikko KI
    Biochem J; 1988 Feb; 249(3):753-7. PubMed ID: 3355495
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Measuring serum aminoterminal type III procollagen peptide, 7S domain of type IV collagen, and cardiac troponin T in patients with idiopathic dilated cardiomyopathy and secondary cardiomyopathy.
    Sato Y; Kataoka K; Matsumori A; Sasayama S; Yamada T; Ito H; Takatsu Y
    Heart; 1997 Nov; 78(5):505-8. PubMed ID: 9415013
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum markers of liver fibrosis and histologic severity of fibrosis in resected liver.
    Tsukamoto T; Yamamoto T; Ikebe T; Takemura S; Shuto T; Kubo S; Hirohashi K; Kinoshita H
    Hepatogastroenterology; 2004; 51(57):777-80. PubMed ID: 15143915
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Procollagen type III N-peptide and type IV collagen 7S-domain in the sera of breast cancer patients.
    Narita T; Funahashi H; Satoh Y; Takagi H
    Surg Today; 1993; 23(8):682-6. PubMed ID: 8400671
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical significance of measurement of PIIIP, laminin P1, type IV-C and 7S in patients with chronic liver diseases--with special reference to histological findings].
    Sato S
    Nihon Shokakibyo Gakkai Zasshi; 1992 Sep; 89(9):2007-15. PubMed ID: 1404988
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Connective tissue metabolites in serum as markers of disease activity in patients with rheumatoid arthritis.
    Hørslev-Petersen K; Bentsen KD; Halberg P; Junker P; Kivirikko KI; Majamaa K; Risteli L; Risteli J; Lorenzen I
    Clin Exp Rheumatol; 1988; 6(2):129-34. PubMed ID: 2846219
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early decrease in serum IV-7S levels during IFN treatment predicts anti-fibrogenic effect in nonresponders with chronic hepatitis C.
    Abe S; Narita R; Hiura M; Jia DM; Tabaru A; Otsuki M
    J Gastroenterol; 2004; 39(3):247-54. PubMed ID: 15065002
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.